Literature DB >> 24161494

De novo deletion of FMN2 in a girl with mild non-syndromic intellectual disability.

Mohammed Almuqbil1, Fadi F Hamdan, Géraldine Mathonnet, Bernard Rosenblatt, Myriam Srour.   

Abstract

We present the case of a child with mild non-syndromic intellectual disability in whom array genomic hybridization revealed a de novo heterozygous deletion involving only one gene, FMN2. FMN2 encodes FORMIN-2, a member of the formin homology family, which is primarily expressed in the developing and mature brain, and has an important role in cytoskeletal organization and actin nucleation. A heterozygous deletion of FMN2 along with 2 other genes has been recently reported in a boy with non-syndromic intellectual disability. This report provides further support for the important role of FMN2 in brain development and cognition.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Chromosome 1q43; FMN2; FORMIN-2; Intellectual disability

Mesh:

Substances:

Year:  2013        PMID: 24161494     DOI: 10.1016/j.ejmg.2013.10.003

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  9 in total

Review 1.  Actin-based growth cone motility and guidance.

Authors:  Omotola F Omotade; Stephanie L Pollitt; James Q Zheng
Journal:  Mol Cell Neurosci       Date:  2017-03-06       Impact factor: 4.314

2.  FMN2 Makes Perinuclear Actin to Protect Nuclei during Confined Migration and Promote Metastasis.

Authors:  Colleen T Skau; Robert S Fischer; Pinar Gurel; Hawa Racine Thiam; Anthony Tubbs; Michelle A Baird; Michael W Davidson; Matthieu Piel; Gregory M Alushin; Andre Nussenzweig; Patricia S Steeg; Clare M Waterman
Journal:  Cell       Date:  2016-11-10       Impact factor: 41.582

3.  Biallelic truncating mutations in FMN2, encoding the actin-regulatory protein Formin 2, cause nonsyndromic autosomal-recessive intellectual disability.

Authors:  Rosalind Law; Tracy Dixon-Salazar; Julie Jerber; Na Cai; Ansar A Abbasi; Maha S Zaki; Kirti Mittal; Stacey B Gabriel; Muhammad Arshad Rafiq; Valeed Khan; Maria Nguyen; Ghazanfar Ali; Brett Copeland; Eric Scott; Nasim Vasli; Anna Mikhailov; Muhammad Nasim Khan; Danielle M Andrade; Muhammad Ayaz; Muhammad Ansar; Muhammad Ayub; John B Vincent; Joseph G Gleeson
Journal:  Am J Hum Genet       Date:  2014-12-04       Impact factor: 11.025

4.  The Formin Fmn2b Is Required for the Development of an Excitatory Interneuron Module in the Zebrafish Acoustic Startle Circuit.

Authors:  Dhriti Nagar; Tomin K James; Ratnakar Mishra; Shrobona Guha; Shawn M Burgess; Aurnab Ghose
Journal:  eNeuro       Date:  2021-07-09

5.  Burden of de novo mutations and inherited rare single nucleotide variants in children with sensory processing dysfunction.

Authors:  Elysa Jill Marco; Anne Brandes Aitken; Vishnu Prakas Nair; Gilberto da Gente; Molly Rae Gerdes; Leyla Bologlu; Sean Thomas; Elliott H Sherr
Journal:  BMC Med Genomics       Date:  2018-05-25       Impact factor: 3.063

Review 6.  Formins in Human Disease.

Authors:  Leticia Labat-de-Hoz; Miguel A Alonso
Journal:  Cells       Date:  2021-09-27       Impact factor: 6.600

7.  Detecting tandem repeat variants in coding regions using code-adVNTR.

Authors:  Jonghun Park; Mehrdad Bakhtiari; Bernt Popp; Michael Wiesener; Vineet Bafna
Journal:  iScience       Date:  2022-07-19

8.  Formin 2 links neuropsychiatric phenotypes at young age to an increased risk for dementia.

Authors:  Roberto Carlos Agís-Balboa; Paulo S Pinheiro; Nelson Rebola; Cemil Kerimoglu; Eva Benito; Michael Gertig; Sanaz Bahari-Javan; Gaurav Jain; Susanne Burkhardt; Ivana Delalle; Alexander Jatzko; Markus Dettenhofer; Patricia A Zunszain; Andrea Schmitt; Peter Falkai; Julius C Pape; Elisabeth B Binder; Christophe Mulle; Andre Fischer; Farahnaz Sananbenesi
Journal:  EMBO J       Date:  2017-08-02       Impact factor: 11.598

9.  FilaminA and Formin2 regulate skeletal, muscular, and intestinal formation through mesenchymal progenitor proliferation.

Authors:  Gewei Lian; Sneha Kanaujia; Timothy Wong; Volney Sheen
Journal:  PLoS One       Date:  2017-12-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.